Preserved cytochrome c oxidase activity despite mitochondrial DNA depletion in adipose tissue of HIV-infected patients with lipodystrophy

被引：0
|
作者：
Kim, MJ
Jardel, C
Barthélémy, C
Jan, V
Bastard, JP
Chapin, S
Houry, S
Lepan, P
Capeau, J
Lombés, A
机构：
[1] Univ Paris 06, INSERM 582, Inst Mycol, Hop Salpetriere,AP HP, Paris, France
[2] Univ Paris 06, INSERM 680, Fac Med St Antoine, Paris, France
[3] Hop Tenon, Serv Biochim & Hormonol, AP HP, F-75970 Paris, France
[4] Hop Tenon, Serv Chirurg Viscerale, AP HP, F-75970 Paris, France
[5] Hop Rothschild, Serv Chirurg Plast, AP HP, F-75571 Paris, France
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：L8 / L9
页数：2
相关论文
共 50 条
  • [31] Assessing the risk of adipose tissue mitochondrial toxicity in HIV-infected individuals on contemporary NRTI regimens
    Hammond, E.
    Nolan, D.
    McKinnon, E.
    Pace, C.
    Mallal, S.
    ANTIVIRAL THERAPY, 2006, 11 (07) : L6 - L7
  • [32] Mitochondrial DNA depletion in HIV-infected patients is more pronounced with chronic hepatitis C and enhanced following treatment with pegylated interferon plus ribavirin
    de Mendoza, C
    Sánchez-Conde, M
    Timmermans, E
    Buitelaar, M
    de Baar, MP
    Gonzalez-Lahoz, J
    Soriano, V
    ANTIVIRAL THERAPY, 2005, 10 (04) : 557 - 561
  • [33] Differential effects of nucleoside reverse transcriptase inhibitor (NRTI) regimens on adipocyte mitochondrial DNA depletion in HIV-infected patients
    Hammond, E
    Nolan, D
    McKinnon, E
    James, I
    Mallal, S
    ANTIVIRAL THERAPY, 2004, 9 (06) : L11 - L12
  • [34] Effects of Switching from Stavudine to Raltegravir on Subcutaneous Adipose Tissue in HIV-Infected Patients with HIV/HAART-Associated Lipodystrophy Syndrome (HALS). A Clinical and Molecular Study
    Domingo, Pere
    del Mar Gutierrez, Maria
    Miguel Gallego-Escuredo, Jose
    Torres, Ferran
    Maria Mateo, Gracia
    Villarroya, Joan
    de los Santos, Ignacio
    Carles Domingo, Joan
    Villarroya, Francesc
    Del Rio, Luis
    Estrada, Vicente
    Giralt, Marta
    PLOS ONE, 2014, 9 (02):
  • [35] Time on antiretroviral. therapy and mitochondrial DNA content and cytochrome c oxidase activity
    Miró, O
    López, S
    Martínez, E
    Pedrol, E
    Casademont, J
    Cardellach, F
    ANTIVIRAL THERAPY, 2003, 8 (04) : L43 - L43
  • [36] Effects of different antiretroviral treatments on mitochondrial DNA levels in PBMCs of HIV-infected patients
    Tebas, P
    Mondy, K
    De Ronde, A
    Rooj, E
    de Baar, MP
    Henry, K
    Powderly, W
    Claxton, S
    Yarasheski, KE
    ANTIVIRAL THERAPY, 2003, 8 (04) : L44 - L44
  • [37] Association of epicardial adipose tissue with incident coronary heart disease and death in HIV-infected patients
    Guaraldi, G.
    Scaglioni, R.
    Zona, S.
    Orlando, G.
    Carli, F.
    Ligabue, G.
    Besutti, G.
    Menozzi, M.
    Santoro, A.
    Beghetto, B.
    Mussini, C.
    Raggi, Paolo
    ANTIVIRAL THERAPY, 2013, 18 : A10 - A11
  • [38] Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients
    Kotler, DP
    Muurahainen, N
    Grunfeld, C
    Wanke, C
    Thompson, M
    Saag, M
    Bock, D
    Simons, G
    Gertner, JM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (03) : 239 - 252
  • [39] AUTOANTIBODIES IN HIV-INFECTED PATIENTS THAT MODULATE THE CHOLINERGIC ACTIVITY OF HEART AND GUT TISSUE
    DEBRACCO, MME
    BORDA, E
    GALASSI, N
    PEREZBIANCO, R
    STERINBORDA, L
    AUTOIMMUNITY, 1993, 14 (04) : 307 - 314
  • [40] Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels
    Roge, BT
    Calbet, JAL
    Moller, K
    Ullum, H
    Hendel, HW
    Gerstoft, J
    Pedersen, BK
    AIDS, 2002, 16 (07) : 973 - 982
12345